Research Article

Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q Deletion

Table 1

Patient characteristics.

 all (N=8)6q del (+) (N=3)6q del (-) (N=5)

Median Age (old, range)71.5 (58-79)76 (70-79)71 (58-76)

Sex (M/F) (%)5/32/13/2

PS>1 (%)523

Hb <11.5 g/dL (%)633

plt <10×109/L (%)101

β2MG>3mg/L (%)3 (64.3)22

Median M-protein (g/dL)2.65 (0.8-4.28)3.14 (2.13-4.28)2.25 (0.8-3.87)

ISSWM(Low/Int/High) (%)0/4/4 (9/36/55)0/1/20/3/2

B-symptom (%)2 (29.4)11

Hepatomegaly (%)1 (23.8)01

Splenomegaly (%)1 (23.8)01

Lymphadenopathy (%)2(25)02

Cold agglutinin disease202

Infiltration pattern (D/P)7/13/04/1

Plasma cell (%)1.9 (1-3.6)2.0 (1-2.2)1.8 (1.2-3.6)

Lymphoplasmacytic cell (%)3.3 (2.4-8.6)7.1 (2.6-8.6)3.0 (2.4-5.2)

Small lymphocyte (%)39.0 (29.4-62.8)41.6 (35.9-62.8)36.4 (29.4-46.8)

Total neoplastic cell (%)45.7 (36-72.4)46.4 (45-72.4)41.4 (36-50.4)

PS: performance status; Hb: hemoglobin; plt: platelets; β2MG: β2-microglobulin; cCa: calculated Ca; ISSWM: International Prognostic Scoring System for Waldenström Macroglobulinemia.